New Mathematical Modeling Approach To Analyzing Colorectal Cancer Clinical Trial Data

tD33NAt

Active member
Mar 24, 2008
12,519
0
36
Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announced that its Pharsight Consulting Services has developed a mathematical model of tumor growth inhibition, which when combined with baseline prognostic factors, predicts treatment effect with bevacizumab for patients with metastatic colorectal cancer. These results are now published online in the Journal of Clinical Oncology...
1Per2GDpHg8


More...
 
Back
Top